Tomoya Okazaki1, Kenya Kawakita2, Yasuhiro Kuroda2. 1. Emergency Medical Center, Kagawa University Hospital, 1750-1 Ikenobe, Kita, Miki, Kagawa, 761-0793, Japan. tomoyaokazaki4028@gmail.com. 2. Emergency Medical Center, Kagawa University Hospital, 1750-1 Ikenobe, Kita, Miki, Kagawa, 761-0793, Japan.
Abstract
BACKGROUND: Several observational studies have shown that hospital-level intracranial pressure (ICP) monitoring utilization varies considerably in patients with severe traumatic brain injury (TBI). However, the relationship between hospital-level ICP monitoring utilization and clinical functional outcomes is unknown. This study examined whether patients with severe TBI treated at hospitals with high ICP monitoring utilization have better functional outcomes. METHODS: A post hoc analysis of the data from a prospective multicenter cohort study in Japan was undertaken, and included severe TBI patients (Glasgow Come Scale score ≤ 8). The primary exposure was hospital-level ICP monitoring utilization. Patients treated at hospitals with more than 80% ICP monitoring utilization were assigned to a high group and the others to a low group. The primary endpoint was a favorable functional outcome at 6 months after injury, defined as a Glasgow Outcome Scale score of good recovery or moderate disability. We conducted multiple logistic regression analyses adjusted for potential confounders. RESULTS: Of the 427 included patients, 60 were assigned to the high group and 367 to the low group. Multiple logistic regression analysis revealed that patients in the high group had significantly better functional outcome (adjusted odds ratio [OR]: 2.36; 95% confidence interval [CI]: 1.17-4.76; p = 0.016). Multiple logistic regression analysis adjusted for additional confounders supported this result (adjusted OR: 2.30; 95% CI: 1.07-4.92; p = 0.033). CONCLUSION: Treatment at hospitals with high ICP monitoring utilization for severe TBI patients could be associated with better functional outcome.
BACKGROUND: Several observational studies have shown that hospital-level intracranial pressure (ICP) monitoring utilization varies considerably in patients with severe traumatic brain injury (TBI). However, the relationship between hospital-level ICP monitoring utilization and clinical functional outcomes is unknown. This study examined whether patients with severe TBI treated at hospitals with high ICP monitoring utilization have better functional outcomes. METHODS: A post hoc analysis of the data from a prospective multicenter cohort study in Japan was undertaken, and included severe TBI patients (Glasgow Come Scale score ≤ 8). The primary exposure was hospital-level ICP monitoring utilization. Patients treated at hospitals with more than 80% ICP monitoring utilization were assigned to a high group and the others to a low group. The primary endpoint was a favorable functional outcome at 6 months after injury, defined as a Glasgow Outcome Scale score of good recovery or moderate disability. We conducted multiple logistic regression analyses adjusted for potential confounders. RESULTS: Of the 427 included patients, 60 were assigned to the high group and 367 to the low group. Multiple logistic regression analysis revealed that patients in the high group had significantly better functional outcome (adjusted odds ratio [OR]: 2.36; 95% confidence interval [CI]: 1.17-4.76; p = 0.016). Multiple logistic regression analysis adjusted for additional confounders supported this result (adjusted OR: 2.30; 95% CI: 1.07-4.92; p = 0.033). CONCLUSION: Treatment at hospitals with high ICP monitoring utilization for severe TBI patients could be associated with better functional outcome.
Authors: David M Panczykowski; Ava M Puccio; Bobby J Scruggs; Joshua S Bauer; Allison J Hricik; Sue R Beers; David O Okonkwo Journal: J Neurotrauma Date: 2011-12-01 Impact factor: 5.269
Authors: Andrew I R Maas; David K Menon; P David Adelson; Nada Andelic; Michael J Bell; Antonio Belli; Peter Bragge; Alexandra Brazinova; András Büki; Randall M Chesnut; Giuseppe Citerio; Mark Coburn; D Jamie Cooper; A Tamara Crowder; Endre Czeiter; Marek Czosnyka; Ramon Diaz-Arrastia; Jens P Dreier; Ann-Christine Duhaime; Ari Ercole; Thomas A van Essen; Valery L Feigin; Guoyi Gao; Joseph Giacino; Laura E Gonzalez-Lara; Russell L Gruen; Deepak Gupta; Jed A Hartings; Sean Hill; Ji-Yao Jiang; Naomi Ketharanathan; Erwin J O Kompanje; Linda Lanyon; Steven Laureys; Fiona Lecky; Harvey Levin; Hester F Lingsma; Marc Maegele; Marek Majdan; Geoffrey Manley; Jill Marsteller; Luciana Mascia; Charles McFadyen; Stefania Mondello; Virginia Newcombe; Aarno Palotie; Paul M Parizel; Wilco Peul; James Piercy; Suzanne Polinder; Louis Puybasset; Todd E Rasmussen; Rolf Rossaint; Peter Smielewski; Jeannette Söderberg; Simon J Stanworth; Murray B Stein; Nicole von Steinbüchel; William Stewart; Ewout W Steyerberg; Nino Stocchetti; Anneliese Synnot; Braden Te Ao; Olli Tenovuo; Alice Theadom; Dick Tibboel; Walter Videtta; Kevin K W Wang; W Huw Williams; Lindsay Wilson; Kristine Yaffe Journal: Lancet Neurol Date: 2017-11-06 Impact factor: 44.182
Authors: Randall M Chesnut; Nancy Temkin; Nancy Carney; Sureyya Dikmen; Carlos Rondina; Walter Videtta; Gustavo Petroni; Silvia Lujan; Jim Pridgeon; Jason Barber; Joan Machamer; Kelley Chaddock; Juanita M Celix; Marianna Cherner; Terence Hendrix Journal: N Engl J Med Date: 2012-12-12 Impact factor: 91.245
Authors: Aziz S Alali; Robert A Fowler; Todd G Mainprize; Damon C Scales; Alexander Kiss; Charles de Mestral; Joel G Ray; Avery B Nathens Journal: J Neurotrauma Date: 2013-07-11 Impact factor: 5.269
Authors: Ewout W Steyerberg; Nino Mushkudiani; Pablo Perel; Isabella Butcher; Juan Lu; Gillian S McHugh; Gordon D Murray; Anthony Marmarou; Ian Roberts; J Dik F Habbema; Andrew I R Maas Journal: PLoS Med Date: 2008-08-05 Impact factor: 11.069